PsyBio Therapeutics Corp.
PSYBF · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 6/30/2020 | |
|---|---|---|---|---|
| Market Cap | $3 | $17 | $10 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $17 | $9 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$2 | -$2 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$10 | $0 | $0 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$11 | -$6 | -$0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.042 | -0.1 | -0.2 | 0 |
| % Growth | 58% | 50% | – | – |
| Operating Cash Flow | -$3 | -$7 | -$1 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$7 | -$1 | -$0 |